Achieve Pricing Flexibility & Accuracy in the Face of the IRA

Presented by

Erin Bayliss, Principal Consultant, Keyrus; Jenna Pabodie, Consultant, Keyrus

About this talk

The life sciences industry has always been faced with a complex process that is prone to errors when forecasting gross to net sales. There are many variables that need to be considered when arriving at net sales including rebates, Medicare rebates, chargebacks, returns, admin fees, and more. Ineffective gross-to-net planning leads to auditing and compliance repercussions, an inability to verify pricing adjustments, and insufficient systems and procedures. Now life science companies are additionally coming head-to-head with the impacts arising from the Inflation Reduction Act including negotiations with Medicare & Medicaid as well as inflation considerations. In today’s BrightTALK, we show how organizations can leverage the Anaplan platform to achieve pricing flexibility & accuracy in the face of the Inflation Reduction Act.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (28)
Subscribers (585)
Keyrus is a data analytics and digital consulting company focused on helping companies get the most out of their data. This channel features webinars and how to's that can help you uncover insights using tools like Tableau, Alteryx, AWS, Anaplan, Talend, and more.